Live feed03:00:55·1249dPRReleasevia QuantisnowHUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside ChinaByQuantisnow·Wall Street's wire, on your screen.HCM· HUTCHMED (China) LimitedTAK· Takeda Pharmaceutical Company LimitedHealth Care
